Bios Equity Partners II, LP

10% owner at Azitra, Inc. · on record since Jun 23, 2023
Director at ACTUATE CORP · on record since Aug 20, 2024
10% owner at ACTUATE CORP · on record since Aug 20, 2024
10% owner at Lantern Pharma Inc. · on record since Jun 16, 2020
10% owner at IN8BIO, INC. · on record since Jul 29, 2021
10% owner at COGNITION THERAPEUTICS INC · on record since Feb 1, 2022
Director at IN8BIO, INC. · on record since Aug 30, 2022
Director at COGNITION THERAPEUTICS INC · on record since Nov 29, 2022

Insider trading activity of Bios Equity Partners II, LP

Transactions on record: 17; since Sep 29, 2022

Open-market buys: 3; $50.5K

Open-market sells: 9; $676.3K

Companies traded: 3; last filing Jun 11, 2024

Figures computed from official regulatory filings — .

Companies where Bios Equity Partners II, LP has traded

COGNITION THERAPEUTICS INC2 tx · Jun 11, 2024
Lantern Pharma Inc.9 tx · $676.3K · Feb 29, 2024
IN8BIO, INC.6 tx · $50.5K · Dec 14, 2023

Track record of Bios Equity Partners II, LP

Statistical track record

Free account

Open-market buys: 6

Last buy: Dec 13, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Bios Equity Partners II, LP

Co-insiders of Bios Equity Partners II, LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
COGNITION THERAPEUTICS INCListing on record	Jun 11, 2024	AwardD (derivative)	8,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
COGNITION THERAPEUTICS INCListing on record	Jun 11, 2024	Award	8,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-10,620	4.40 USD	$46.7K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-6,909	4.85 USD	$33.5K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-4,649	4.40 USD	$20.5K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-51,608	4.85 USD	$250.3K	Unusual size	SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-34,731	4.40 USD	$152.8K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-1,832	4.87 USD	$8.9K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-15,780	4.85 USD	$76.5K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-4,185	4.87 USD	$20.4K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-13,686	4.87 USD	$66.7K		SEC
IN8BIO, INC.Listing on record	Dec 14, 2023	BuyD (derivative)	574,241	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
IN8BIO, INC.Listing on record	Dec 14, 2023	BuyD (derivative)	574,241	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
IN8BIO, INC.Listing on record	Dec 14, 2023	BuyD (derivative)	574,241	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
IN8BIO, INC.Listing on record	Sep 29, 2022	Buy	3,070	2.02 USD	$6.2K	conv 54ClusterFirst in 12mo	SEC
IN8BIO, INC.Listing on record	Sep 29, 2022	Buy	2,913	2.02 USD	$5.9K	conv 54ClusterFirst in 12mo	SEC
IN8BIO, INC.Listing on record	Sep 29, 2022	Buy	19,017	2.02 USD	$38.4K	conv 54ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
COGNITION THERAPEUTICS INCListing on record	Jun 11, 2024	AwardD (derivative)	8,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
COGNITION THERAPEUTICS INCListing on record	Jun 11, 2024	Award	8,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-10,620	4.40 USD	$46.7K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-6,909	4.85 USD	$33.5K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-4,649	4.40 USD	$20.5K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-51,608	4.85 USD	$250.3K	Unusual size	SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-34,731	4.40 USD	$152.8K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-1,832	4.87 USD	$8.9K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-15,780	4.85 USD	$76.5K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-4,185	4.87 USD	$20.4K		SEC
Lantern Pharma Inc.Listing on record	Feb 29, 2024	Sell	-13,686	4.87 USD	$66.7K		SEC
IN8BIO, INC.Listing on record	Dec 14, 2023	BuyD (derivative)	574,241	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
IN8BIO, INC.Listing on record	Dec 14, 2023	BuyD (derivative)	574,241	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
IN8BIO, INC.Listing on record	Dec 14, 2023	BuyD (derivative)	574,241	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
IN8BIO, INC.Listing on record	Sep 29, 2022	Buy	3,070	2.02 USD	$6.2K	conv 54ClusterFirst in 12mo	SEC
IN8BIO, INC.Listing on record	Sep 29, 2022	Buy	2,913	2.02 USD	$5.9K	conv 54ClusterFirst in 12mo	SEC
IN8BIO, INC.Listing on record	Sep 29, 2022	Buy	19,017	2.02 USD	$38.4K	conv 54ClusterFirst in 12mo	SEC